[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100504002":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":31,"responsibleParty":63,"collaborators":19,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":70,"acronym":19,"eligibilityCriteria":71,"healthyVolunteers":68,"sex":72,"minAge":73,"maxAge":19,"enrollmentInfo":74,"targetDuration":19,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":84,"overallStatus":34,"whyStopped":19,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Massachusetts General Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Cardiac Lifestyle Program","EXPERIMENTAL","Participants will complete study procedures as follows:\n\n* Baseline in-clinic visit with research team doctor for history and physical and the completion of questionnaires.\n* 6 virtual group classes alternating with 6 in-person group classes.\n* Semi-structured exit interview.",[13],"Behavioral: Cardiac Lifestyle Program",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"BEHAVIORAL","12-week, tailored nutrition and physical activity program comprised of virtual and in-person classes.",[9],null,[21],{"name":22,"affiliation":5,"role":23},"Gabriela Hobbs, MD","PRINCIPAL_INVESTIGATOR",[25,29],{"name":22,"role":26,"phone":27,"phoneExt":19,"email":28},"CONTACT","617-724-1124","ghobbs@partners.org",{"name":30,"role":26,"phone":27,"phoneExt":19,"email":28},"Gabriella Hobbs, MD",[32,48,56],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Brigham and Women's Hospital","RECRUITING","Boston","Massachusetts","02215","United States","US",{"type":41,"coordinates":42},"Point",[43,44],-71.05977,42.35843,{"lat":44,"lon":43},[47],{"name":22,"role":26,"phone":27,"phoneExt":19,"email":28},{"facility":49,"status":50,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":51,"geoPoint":53,"contacts":54},"Dana-Farber Cancer Institute","NOT_YET_RECRUITING",{"type":41,"coordinates":52},[43,44],{"lat":44,"lon":43},[55],{"name":22,"role":26,"phone":27,"phoneExt":19,"email":28},{"facility":57,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":58,"geoPoint":60,"contacts":61},"Massachusetts General Hospital Cancer Center",{"type":41,"coordinates":59},[43,44],{"lat":44,"lon":43},[62],{"name":22,"role":26,"phone":27,"phoneExt":19,"email":28},{"type":23,"investigatorFullName":64,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"Gabriela Hobbs","Principal Investigator","100504002","i-can-move-with-purpose-now-a-pilot-lifestyle-intervention-study-in-myeloproliferative-neoplasm-patients-100504002",false,"NCT05842603","I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients","Inclusion Criteria:\n\n-≥18 years of age\n\n* Diagnosed with an MPN by WHO 2016 criteria,22 including essential thrombocythemia (ET), polycythemia vera (PV), prefibrotic myelofibrosis (pre-MF), myelofibrosis (MF), and MPN not otherwise specified (NOS). Within MF patients, only patients who are low or intermediate-1 risk by the Dynamic International Prognostic Scoring System (DIPSS) are eligible.23 All risk groups are eligible for the remaining MPN subtypes.\n* Eastern Cooperative Oncology Group (ECOG) performance status 0-1\n* Must have at least one cardiovascular risk factor including: Body mass index (BMI) \\>25 kg\u002Fm2, hypertension, hyperlipidemia, diabetes mellitus or pre-diabetes or metabolic syndrome, or any prior history of cardiovascular disease, transient ischemic attack, stroke, or peripheral vascular disease. Patients not meeting any cardiovascular risk criteria must receive prior approval from the PI to participate in this study.\n\nExclusion Criteria:\n\n\\-- MF patients with intermediate-2 or high-risk disease by DIPSS\n\n* ECOG performance status \\>2.\n* Any injury or medical condition that would prohibit being able to safely perform exercise, as determined by the treating physician.","ALL","18 Years",{"count":75,"type":76},30,"ESTIMATED","INTERVENTIONAL",[79],"NA","The goal of this study is to see if patients with myeloproliferative disorders are able to successfully complete the Cardiac Lifestyle Program(CLP). The goal of the CLP is to teach patients how to become more active and eat healthier foods.\n\nThe name of the intervention used in this research study is:\n\nCardiac Lifestyle Program (a 12-week, tailored nutrition and physical activity program)",[82,83],"Myeloproliferative Disorders","Leukemia",[82,83],"2025-09-22",{"date":87,"type":88},"2025-09-25","ACTUAL",{"date":90,"type":88},"2024-03-01",{"date":92,"type":76},"2027-01-01",{"name":5,"class":6},3]